《大行報告》瑞信上調比亞迪(01211.HK)目標價至420元 去年業績勝預期
瑞信發表研究報告指,比亞迪(01211.HK)發盈喜,料其2022年度淨利潤爲160至170億元人民幣,按年增長425至458%。由於銷量按季增長27%,意味着2022年第四季的淨利潤達到67至77億元人民幣的歷史新高,按季錄得改善。該行提到,第四季優於預期的利潤率最令人驚喜,故上調集團2022至24年的盈測4.6至6.7%,目標價由410元上調至420元,
該行提到,展望今年,集團管理層指引全年銷量按年增長60%至300萬輛,其中,插電式混合動力汽車及純電動汽車銷量各自爲150萬輛。(sl/~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.